- In October 2023, NeuroMetrix partnered with the National Fibromyalgia Association (NFA) to improve the quality of life for individuals with fibromyalgia. Through this collaboration, NeuroMetrix would sponsor the NFA’s mission, providing essential education, support, and advocacy for fibromyalgia patients, working together to raise awareness and enhance the care and management of the condition
- In April 2021, DJO, a subsidiary of Colfax Corporation, acquired MedShape, Inc., a prominent innovator in medical devices for fracture fixation, joint fusion, and soft tissue injury repair. This acquisition bolstered DJO's portfolio of orthopedic solutions, enhancing its ability to offer advanced treatments and improve patient outcomes, solidifying its position in the medical device industry
- In September 2020, NeuroMetrix launched the Quell App, specifically designed for Apple Watch users, to provide relief for knee, foot, and leg pain. The wearable TENS (Transcutaneous Electrical Nerve Stimulation) device is available over-the-counter and offers a non-invasive solution for chronic pain management, aiming to improve the daily lives of users with its easy-to-use, effective technology
Frequently Asked Questions
The market is segmented based on Segmentation, By Surgery Procedures (Direct Nerve Repair, Nerve Grafting, and Stem Cell Therapy), Product (Portable and Desktop), End-User (Hospitals, Physiotherapy Clinics, Rehabilitation Centers, Home care, and Others), Application (Chronic Pain and Acute Pain) – Industry Trends and Forecast to 2032
.
The Global Transcutaneous Electrical Nerve Stimulators Market size was valued at USD 334.31 USD Million in 2024.
The Global Transcutaneous Electrical Nerve Stimulators Market is projected to grow at a CAGR of 4.11% during the forecast period of 2025 to 2032.
The major players operating in the market include Boston Scientific Corporation , BTL , DJO LLC , Medtronic , Nevro Corp. , NeuroMetrixInc. , Abbott , Chirag Electronics Private Limited , Laborie , Zynex Medical , EMS Physio Ltd Cochlear Ltd , Aleva Neurotherapeutics SA , NeuroPace Inc. , OMRON Corporation , and BioMedical Life Systems .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
